Epigral Reports Q4FY25 PAT Growth of 13% to Rs 870 Million
ECONOMY & POLICY

Epigral Reports Q4FY25 PAT Growth of 13% to Rs 870 Million

Epigral Limited, a leading integrated chemical manufacturer in India, announced its financial results for the quarter ended March 31, 2025. The company reported a 13% year-on-year rise in profit after tax (PAT) at Rs 870 million in Q4FY25, compared to Rs 770 million in Q4FY24. Revenue for the quarter stood at Rs 6.31 billion, up 20% from Rs 5.26 billion in the same quarter last year.

Reflecting its strong performance, the company’s balance sheet strengthened further in FY25. Return on capital employed (ROCE) rose to 25% from 18% in FY24, and Net Debt/EBITDA improved significantly to 0.7x from 2.0x. Credit rating was upgraded to CRISIL AA from CRISIL AA-.

Chairman and Managing Director Maulik Patel stated, “We closed FY2025 with the highest-ever revenue of Rs 25.65 billion, a 33% growth over the previous year. This was driven by an 11% volume increase, especially in high-value products. Our Derivatives & Specialty segment grew 24% and now contributes 54% to total revenue, up from 45% in FY24.”

The company plans to expand its CPVC and Epichlorohydrin (ECH) capacities, which are expected to come online in H1FY27 and contribute thereafter. The integrated complex is expected to further benefit once these projects reach full capacity.

Dividend Update:

Epigral’s board proposed a final dividend of Rs 3.5 per equity share, bringing the total dividend for FY2025 to Rs 6.0 per share (60% of the face value of Rs 10).
Strategic & financial highlights for FY2025:
  • Credit rating upgraded to CRISIL AA.
  • Capital expenditure stood at Rs 1.95 billion in FY2025.
  • Successfully raised Rs 3.33 billion via QIP to support growth.
  • CPVC Resin capacity expanded to 75,000 TPA; approved to double to 150,000 TPA.
  • Epichlorohydrin capacity to double to 100,000 TPA.
  • Commissioned CPVC Compound and Chlorotoluenes Value Chain facilities.
Q4FY25 operational & financial highlights:
  • Revenue grew 20% YoY to Rs 6.31 billion.
  • Derivatives & Specialty segment’s revenue contribution rose to 52% from 48% in Q4FY24.
  • EBITDA increased 12% to Rs 1.73 billion, with a margin of 28%.
  • PAT rose 13% to Rs 870 million.
  • Captive chlorine usage increased to 76%.
FY2025 operational & financial summary:
  • Sales volume grew 11%, with overall capacity utilisation at 81% (vs 78% in FY24).
  • Highest-ever revenue at Rs 25.65 billion, up 33% YoY.
  • Derivatives & Specialty business contributed 54% to revenue.
  • EBITDA rose 48% to Rs 7.11 billion (vs Rs 4.81 billion in FY24).
  • EBITDA margin improved to 28% from 25%.
  • PAT surged 82% to Rs 3.57 billion.

(BSE)

Image Source: Image Generated by ChatGPT

Epigral Limited, a leading integrated chemical manufacturer in India, announced its financial results for the quarter ended March 31, 2025. The company reported a 13% year-on-year rise in profit after tax (PAT) at Rs 870 million in Q4FY25, compared to Rs 770 million in Q4FY24. Revenue for the quarter stood at Rs 6.31 billion, up 20% from Rs 5.26 billion in the same quarter last year.Reflecting its strong performance, the company’s balance sheet strengthened further in FY25. Return on capital employed (ROCE) rose to 25% from 18% in FY24, and Net Debt/EBITDA improved significantly to 0.7x from 2.0x. Credit rating was upgraded to CRISIL AA from CRISIL AA-.Chairman and Managing Director Maulik Patel stated, “We closed FY2025 with the highest-ever revenue of Rs 25.65 billion, a 33% growth over the previous year. This was driven by an 11% volume increase, especially in high-value products. Our Derivatives & Specialty segment grew 24% and now contributes 54% to total revenue, up from 45% in FY24.”The company plans to expand its CPVC and Epichlorohydrin (ECH) capacities, which are expected to come online in H1FY27 and contribute thereafter. The integrated complex is expected to further benefit once these projects reach full capacity.Dividend Update:Epigral’s board proposed a final dividend of Rs 3.5 per equity share, bringing the total dividend for FY2025 to Rs 6.0 per share (60% of the face value of Rs 10).Strategic & financial highlights for FY2025:Credit rating upgraded to CRISIL AA.Capital expenditure stood at Rs 1.95 billion in FY2025.Successfully raised Rs 3.33 billion via QIP to support growth.CPVC Resin capacity expanded to 75,000 TPA; approved to double to 150,000 TPA.Epichlorohydrin capacity to double to 100,000 TPA.Commissioned CPVC Compound and Chlorotoluenes Value Chain facilities.Q4FY25 operational & financial highlights:Revenue grew 20% YoY to Rs 6.31 billion.Derivatives & Specialty segment’s revenue contribution rose to 52% from 48% in Q4FY24.EBITDA increased 12% to Rs 1.73 billion, with a margin of 28%.PAT rose 13% to Rs 870 million.Captive chlorine usage increased to 76%.FY2025 operational & financial summary:Sales volume grew 11%, with overall capacity utilisation at 81% (vs 78% in FY24).Highest-ever revenue at Rs 25.65 billion, up 33% YoY.Derivatives & Specialty business contributed 54% to revenue.EBITDA rose 48% to Rs 7.11 billion (vs Rs 4.81 billion in FY24).EBITDA margin improved to 28% from 25%.PAT surged 82% to Rs 3.57 billion.(BSE)Image Source: Image Generated by ChatGPT

Next Story
Infrastructure Transport

Large Format Store Planned At M G Road Metro Station

M G Road station in Bengaluru is set to host the city’s first large-format commercial and experience space, with planning led by Bangalore Metro Rail Corporation Limited. BMRCL has invited proposals to develop and operate a central business district destination at the Purple?Pink Line interchange. The plan positions the station as a commercial hub designed to serve a broad commuter base across the city. The proposal is part of a broader effort to activate transit nodes commercially. Tender documents set a minimum monthly rental of Rs 0.944 million (mn), inclusive of GST, for the large-format..

Next Story
Infrastructure Energy

Government Cancels Auction Of Eleven Critical Mineral Blocks

The government has cancelled the auction of 11 critical and strategic mineral blocks after receiving a poor investor response and failing to attract a sufficient number of qualified bidders. The decision represents a setback to plans to ramp up domestic exploration and production of critical minerals amid global supply chain disruptions and rising demand for materials used in clean energy and advanced technologies. The mines ministry issued an annulment notice setting out the reasons for the cancellations. The annulment notice indicated that the auction process for five mineral blocks was canc..

Next Story
Infrastructure Energy

Gujarat Pushes Biogas Growth With 193 Operational Units

Gujarat has operationalised 193 biogas plants across the state and is planning to add 60 more units as part of a broader push to scale up clean and sustainable energy solutions. The existing plants, established under various government-supported schemes, process organic waste including cattle dung and agricultural residue to produce biogas and a nutrient-rich slurry. The output is mainly used for cooking and other energy needs in rural and semi-urban communities, while also improving local waste management practices. The Gujarat Energy Development Agency (GEDA) is leading the initiative and is..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement